Gonzalez Patricia Paola 4

What Happened

• Patricia Paola Gonzalez, a director of Abbott Laboratories (ABT), was granted 321 shares as a director award on 2026-03-31. The award is reported as a derivative grant at $102.67 per unit, totaling $32,957. This was an award (not an open‑market purchase or sale).

Key Details

• Transaction date: 2026-03-31; Filing date: 2026-04-02 (appears timely).
• Grant: 321 shares (derivative stock-equivalent units) at $102.67 each; total value reported $32,957.
• Shares owned after transaction: not specified in the Form 4 filing.
• Footnote F1: Director fees were credited to a stock-equivalent unit account in a grantor trust and are generally paid in cash at age 65 or upon retirement; units earn returns as if invested in Abbott shares.
• Footnote F2: Balance includes units acquired under a dividend reinvestment feature.
• Transaction code: A (award/grant); derivative securities (not an immediate transfer of tradable shares).

Context

• This is a routine director compensation award credited as stock-equivalent units rather than an open-market buy or sale. Such awards typically reflect board pay practices and are paid out later in cash (per F1), so they should be interpreted as compensation reporting rather than a direct bullish/bearish trading signal.